These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7733607)

  • 21. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
    Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
    JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nocturnal glucose control with an artificial pancreas at a diabetes camp.
    Phillip M; Battelino T; Atlas E; Kordonouri O; Bratina N; Miller S; Biester T; Stefanija MA; Muller I; Nimri R; Danne T
    N Engl J Med; 2013 Feb; 368(9):824-33. PubMed ID: 23445093
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier.
    Bruttomesso D; Farret A; Costa S; Marescotti MC; Vettore M; Avogaro A; Tiengo A; Dalla Man C; Place J; Facchinetti A; Guerra S; Magni L; De Nicolao G; Cobelli C; Renard E; Maran A
    J Diabetes Sci Technol; 2009 Sep; 3(5):1014-21. PubMed ID: 20144414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of multiple daily insulin therapy with continuous subcutaneous insulin infusion therapy in adolescents with type 1 diabetes mellitus: a single-center experience from Turkey.
    Abaci A; Atas A; Unuvar T; Demir K; Bober E; Büyükgebiz A
    J Pediatr Endocrinol Metab; 2009 Jun; 22(6):539-45. PubMed ID: 19694201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What is hypoglycemia in patients with well-controlled type 1 diabetes treated by subcutaneous insulin pump with use of the continuous glucose monitoring system?
    Larsen J; Ford T; Lyden E; Colling C; Mack-Shipman L; Lane J
    Endocr Pract; 2004; 10(4):324-9. PubMed ID: 15760775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with intraperitoneal insulin infusion from implantable programmable systems in type 1 (insulin-dependent) diabetes mellitus previously treated by external pumps.
    Renard E; Lauton D; Bonifacj C; Costalat G; Jacques D; Bringer J; Jaffiol C
    Diabete Metab; 1993; 19(4):364-71. PubMed ID: 8293863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intraperitoneal insulin infusion (using implantable pump) and subcutaneous insulin administration: preliminary results of a crossover study.
    Jeandidier N; Pinget M; Keipes M; Louy S; Vetter A; Réville P
    Transplant Proc; 1992 Jun; 24(3):948-9. PubMed ID: 1604678
    [No Abstract]   [Full Text] [Related]  

  • 29. A recent survey confirms the efficacy and the safety of implanted insulin pumps during long-term use in poorly controlled type 1 diabetes patients.
    Schaepelynck P; Renard E; Jeandidier N; Hanaire H; Fermon C; Rudoni S; Catargi B; Riveline JP; Guerci B; Millot L; Martin JF; Sola A;
    Diabetes Technol Ther; 2011 Jun; 13(6):657-60. PubMed ID: 21470000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is Pump Therapy for All with Type 1 Diabetes?
    Wilson DM
    Diabetes Technol Ther; 2016 May; 18(5):280-1. PubMed ID: 27159783
    [No Abstract]   [Full Text] [Related]  

  • 31. The renaissance of insulin pump treatment in childhood type 1 diabetes.
    Tamborlane WV; Swan K; Sikes KA; Steffen AT; Weinzimer SA
    Rev Endocr Metab Disord; 2006 Sep; 7(3):205-13. PubMed ID: 17160722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study of MiniMed 640G Insulin Pump with SmartGuard in Prevention of Low Glucose Events in Adults with Type 1 Diabetes (SMILE): Design of a Hypoglycemia Prevention Trial with Continuous Glucose Monitoring Data as Outcomes.
    De Valk HW; Lablanche S; Bosi E; Choudhary P; Silva JD; Castaneda J; Vorrink L; De Portu S; Cohen O
    Diabetes Technol Ther; 2018 Nov; 20(11):758-766. PubMed ID: 30325656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of "brittle" diabetes with a preprogrammable implanted insulin pump delivering intraperitoneal insulin.
    Wood DF; Goodchild K; Guillou P; Thomas DJ; Johnston DG
    BMJ; 1990 Nov; 301(6761):1143-4. PubMed ID: 2252927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Home Use of an Artificial Beta Cell in Type 1 Diabetes.
    Thabit H; Tauschmann M; Allen JM; Leelarathna L; Hartnell S; Wilinska ME; Acerini CL; Dellweg S; Benesch C; Heinemann L; Mader JK; Holzer M; Kojzar H; Exall J; Yong J; Pichierri J; Barnard KD; Kollman C; Cheng P; Hindmarsh PC; Campbell FM; Arnolds S; Pieber TR; Evans ML; Dunger DB; Hovorka R
    N Engl J Med; 2015 Nov; 373(22):2129-2140. PubMed ID: 26379095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin pump treatment in children and adolescents with type 1 diabetes.
    Hofer S; Meraner D; Koehle J
    Minerva Pediatr; 2012 Aug; 64(4):433-8. PubMed ID: 22728614
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin pump therapy in young children with type 1 diabetes.
    Bougnères PF; Landier F; Lemmel C; Mensire A; Chaussain JL
    J Pediatr; 1984 Aug; 105(2):212-7. PubMed ID: 6747753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of use of specific features of subcutaneous insulin infusion systems and their relationship to metabolic control in patients with type 1 diabetes.
    Quirós C; Patrascioiu I; Giménez M; Vinagre I; Vidal M; Jansà M; Conget I
    Endocrinol Nutr; 2014; 61(6):318-22. PubMed ID: 24533929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
    Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
    Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiological characterization of diabetic patients on therapy with continuous subcutaneous insulin infusion and continuous glucose monitoring in real time.
    Aristizábal N; Ramírez A; Hincapié-García J; Laiton E; Aristizábal C; Cuesta D; Monsalve C; Hincapié G; Zapata E; Abad V; Delgado MR; Torres JL; Palacio A; Botero J;
    Endocrinol Nutr; 2015 Nov; 62(9):451-7. PubMed ID: 26521154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the effectiveness of long-term insulin pump therapy using a combined goal of HbA
    Quirós C; Viñals C; Giménez M; Roca D; Conget I
    Endocrinol Diabetes Nutr (Engl Ed); 2019 Nov; 66(9):534-539. PubMed ID: 31133475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.